Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis-Reference-Cited by-同舟云学术

Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis

Published:2020-08 Issue:8 Volume:17 Page:911-917
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Berger Christopher A.¹^ORCID,Alipanah Narges¹,Kheir Fayez²,Ruminjo Joseph K.³,Nahid Payam¹^ORCID,Thomson Carey⁴⁵

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCSF Center for Tuberculosis, University of California, San Francisco, California

2. Tulane University School of Medicine, New Orleans, Louisiana

3. American Thoracic Society, New York, New York

4. Division of Pulmonary and Critical Care, Department of Medicine, Mount Auburn Hospital, Cambridge, Massachusetts; and

5. Harvard Medical School, Boston, Massachusetts

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference21 articles.

1. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

2. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

3. World Health Organization (WHO). WHO consolidated guidlines on drug-resistant tuberculosis treatment. Geneva, Switzerland: WHO; 2019.

4. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

5. Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial Therapy According to Clinical Syndromes;2023 Nelson’s Pediatric Antimicrobial Therapy;2023-03-01

2. Principles of Anti-Infective Therapy;Principles and Practice of Pediatric Infectious Diseases;2023

3. Pulmonary Tuberculosis-Related Ischemic Stroke: A Retrospective Case Control Study;Journal of Inflammation Research;2022-07

4. Tuberculosis and pharmacological interactions: A narrative review;Current Research in Pharmacology and Drug Discovery;2021